Robert Millman Email

Startup CEO and Founder . Vesigen Therapeutics

Current Roles

Employees:
54
Revenue:
$8.4M
About
Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables us to deliver a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets. Our team is committed to leveraging ARMMs technology to enable new therapies and address currently unmet medical needs.
Vesigen Therapeutics Address
790 Memorial Drive
Cambridge, MA
Vesigen Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.